As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

United States infectious disease biomarker testing market is expected to witness double digit CAGR during the forecast period. Key factors propelling the growth of United States infectious disease biomarker testing market include growing demand for novel molecular diagnostics testing tools due to increasing cases of coronavirus and presence of leading market players in the country. Furthermore, frequent outbreak of various infectious diseases is also acting as a major growth driver for this market. The presence of highly developed healthcare system coupled with increasing fund by government for R&D activities in biomarker testing is augmenting the growth of United States infectious disease biomarker testing market. Additionally, advancements in molecular techniques and growth in the biomarker identification market are also expected to drive the United States infectious disease biomarker testing market through 2025.

United States infectious disease biomarker testing market can be categorized based on product, application, technology, pathogen, end user and region. Based on technology, the market can be segmented into PCR, NGS, ELISA or EIA, IHC, ISH and others. Among these, PCR dominated the market in 2019 due to high popularity and adoption of PCR based products compared to other technologies. However, NGS technology is expected to witness fastest growth during the forecast period owing to the decreasing prices of NGS-based tests.

Based on end user, United States infectious disease biomarker testing market can be segmented into hospitals and clinics, diagnostic centers, research laboratories and others. Among them, hospitals and clinics segment is anticipated to undergo high growth in terms of revenue through 2025 as they have laboratories equipped with fully automated diagnostic instruments including NGS and PCR for providing better medical diagnostic results.

Major players operating in the United States infectious disease biomarker testing market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Hologic, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Hoffmann-La Roche Inc., Quest Diagnostics Incorporated and Qiagen Sciences, Inc., among others. The market players are undergoing partnerships and alliances to strengthen their business position in United States.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of United States infectious disease biomarker testing market from 2015 to 2018.
  • To estimate and forecast the market size of United States infectious disease biomarker testing market from 2019 to 2025 and growth rate until 2025.
  • to classify and forecast United States infectious disease biomarker testing market based on product, application, technology, pathogen, end user, company and regional distribution.
  • To identify dominant region or segment in the United States infectious disease biomarker testing market.
  • To identify drivers and challenges for United States infectious disease biomarker testing market.
  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States infectious disease biomarker testing market.
  • To conduct pricing analysis for United States infectious disease biomarker testing market.
  • To identify and analyze the profile of leading players operating in United States infectious disease biomarker testing market.
  • To identify key sustainable strategies adopted by market players in United States infectious disease biomarker testing market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of infectious disease biomarker testing system manufacturers across United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across United States.

TechSci Research calculated the market size of United States infectious disease biomarker testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease biomarker testing system manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease biomarker testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as infectious disease biomarker testing system manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States infectious disease biomarker testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Infectious Disease Biomarker Testing Market, By Product:
    • Assays
    • Platforms
  • United States Infectious Disease Biomarker Testing Market, By Application:
    • Respiratory Infection
    • Sexually Transmitted Infection
    • Bloodstream and Hospital-Acquired Infection
    • Urinary Tract Infection
    • Gastro-Intestinal Infection
    • Central Nervous System Infection
    • Others
  • United States Infectious Disease Biomarker Testing Market, By Technology:
    • PCR
    • NGS
    • ELISA or EIA
    • IHC
    • ISH
    • Others
  • United States Infectious Disease Biomarker Testing Market, By Pathogen:
    • Virus
      • Influenza
      • HIV-AIDS
      • Hepatitis
      • HPV
      • Others
    • Bacteria
      • Tuberculosis
      • CT/NG
      • Hospital-Acquired Infection
      • Others
  • United States Infectious Disease Biomarker Testing Market, By End User:
    • Hospitals and Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Others
  • United States Infectious Disease Biomarker Testing Market, By Region:
    • North-East
    • Mid-West
    • West
    • South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States infectious disease biomarker testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Infectious Disease Biomarker Testing Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Infectious Disease Biomarker Testing Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Assays, Platforms)

6.2.2.     By Application (Respiratory Infection, Sexually Transmitted Infection, Bloodstream and Hospital-Acquired Infection, Urinary Tract Infection, Gastro-Intestinal Infection, Central Nervous System Infection, Others)

6.2.3.     By Technology (PCR, NGS, ELISA or EIA, IHC, ISH, Others)

6.2.4.     By Pathogen (Virus (Influenza, HIV-AIDS, Hepatitis, HPV, Others), Bacteria (Tuberculosis, CT/NG, Hospital-Acquired Infection, Others)

6.2.5.     By End User (Hospitals and Clinics, Diagnostic Centers, Research Laboratories, Others)

6.2.6.     By Region

6.2.7.     By Company

6.3.  Product Market Map

7.    United States Assay Infectious Disease Biomarker Testing Market Outlook

7.1.  Market Size & Forecast

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By Technology

7.2.3.     By Pathogen

7.2.4.     By End User

8.    United States Platform Infectious Disease Biomarker Testing Market Outlook

8.1.  Market Size & Forecast

8.1.1. By Value

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By Technology

8.2.3.     By Pathogen

8.2.4.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Development

11.  Pricing Analysis

12.  Policy & Regulatory Landscape

13.  Import Export Analysis

14.  United States Economic Profile

15.  Competitive Landscape

15.1.              Competition Outlook

15.2.              Company Profiles

15.2.1.  Abbott Laboratories, Inc.

15.2.2.  Agilent Technologies, Inc.

15.2.3.  Becton, Dickinson and Company

15.2.4.  Bio-Rad Laboratories, Inc.

15.2.5.  Danaher Corporation

15.2.6.  Hologic, Inc.

15.2.7.  PerkinElmer, Inc.

15.2.8.  Thermo Fisher Scientific, Inc.

15.2.9.  Hoffmann-La Roche Inc.

15.2.10.                Quest Diagnostics Incorporated

15.2.11.                Qiagen Sciences, Inc.

16.  Strategic Recommendations

17.  About Us & Disclaimer

 (Note: The companies list can be customized based on the client requirements.)

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com